マルファン症候群の臨床試験の分析：フェーズ別、試験ステータス別、エンドポイント別、スポンサータイプ別、地域別（2023年版）

当レポートでは、マルファン症候群の臨床試験について調査分析し、各国の臨床試験と登録の動向や、主要企業のレビューと臨床試験のリストなどを提供しています。

目次

表のリスト

図のリスト

• レポートガイダンス
• GlobalDataの臨床試験レポートの範囲
• 臨床試験：地域別
• 臨床試験と平均登録数：国別
• アジア太平洋の臨床試験にもっとも寄与している国
• 欧州の臨床試験に寄与している上位5ヶ国
• 北米の臨床試験にもっとも寄与している国
• G7諸国による臨床試験：遺伝性疾患の臨床試験に対するマルファン症候群の割合
• G7諸国の臨床試験：フェーズ別
• G7諸国の臨床試験：試験ステータス別
• 臨床試験：フェーズ別
• 臨床試験：試験ステータス別
• 臨床試験：エンドポイントステータス別
• 臨床試験：スポンサータイプ別
• 著名なスポンサー
• マルファン症候群治療の臨床試験に参加する主要企業
• 著名な薬剤
• 臨床試験プロファイルのスナップショット

付録

List of Tables

List of Tables

• Marfan Syndrome Therapeutics, Global, Clinical Trials by Region, 2023*
• Marfan Syndrome Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2023*
• Marfan Syndrome Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2023*
• Marfan Syndrome Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2023*
• Marfan Syndrome Therapeutics Clinical Trials, Europe, Top Five Countries, 2023*
• Marfan Syndrome Therapeutics Clinical Trials, North America, Top Countries, 2023*
• Proportion of Marfan Syndrome to Genetic Disorders Clinical Trials, G7 Countries (%), 2023*
• Marfan Syndrome Therapeutics, G7 Countries, Clinical Trials by Phase, 2023*
• Marfan Syndrome Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2023*
• Marfan Syndrome Therapeutics, Global, Clinical Trials by Phase, 2023*
• Marfan Syndrome Therapeutics, Global, Clinical Trials by Trial Status, 2023*
• Marfan Syndrome Therapeutics Clinical Trials, Global, by End Point Status, 2023*
• Marfan Syndrome Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2023*
• Marfan Syndrome Therapeutics Clinical Trials, Global, Key Sponsors, 2023*
• Marfan Syndrome Therapeutics Clinical Trials, Global, Top Companies by Phase, 2023*
• Marfan Syndrome Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2023*

List of Figures

List of Figures

• Marfan Syndrome Therapeutics, Global, Clinical Trials by Region (%), 2023*
• Marfan Syndrome Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2023*
• Marfan Syndrome Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2023*
• Marfan Syndrome Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2023*
• Marfan Syndrome Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2023*
• Marfan Syndrome Therapeutics Clinical Trials, North America, Top Countries (%), 2023*
• Proportion of Marfan Syndrome to Genetic Disorders Clinical Trials, G7 Countries (%), 2023*
• Marfan Syndrome Therapeutics, G7 Countries, Clinical Trials by Phase, 2023*
• Marfan Syndrome Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2023*
• Marfan Syndrome Therapeutics, Global, Clinical Trials by Phase (%), 2023*
• Marfan Syndrome Therapeutics, Global, Clinical Trials by Trial Status, 2023*
• Marfan Syndrome Therapeutics Clinical Trials, Global, by End Point Status, 2023*
• Marfan Syndrome Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2023*
• Marfan Syndrome Therapeutics Clinical Trials, Global, Key Sponsors, 2023*
• Marfan Syndrome Therapeutics Clinical Trials, Global, Top Companies by Phase, 2023*
• Marfan Syndrome Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2023*
• GlobalData Methodology

Abstract

GlobalData's clinical trial report, "Marfan Syndrome Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update" provides an overview of Marfan Syndrome Clinical trials scenario. This report provides top line data relating to the clinical trials on Marfan Syndrome. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma - Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

• The report provides a snapshot of the global clinical trials landscape
• Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
• The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
• The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
• The Report provides enrollment trends for the past five years
• Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to Buy

• Assists in formulating key business strategies with regards to investment
• Helps in identifying prominent locations for conducting clinical trials which saves time and cost
• Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
• Supports understanding of trials count and enrollment trends by country in global therapeutics market
• Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
• Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents

List of Tables

List of Figures

• Report Guidance
• GlobalData Clinical Trials Report Coverage
• Clinical Trials by Region
• Clinical Trials and Average Enrollment by Country
• Top Countries Contributing to Clinical Trials in Asia-Pacific
• Top Five Countries Contributing to Clinical Trials in Europe
• Top Countries Contributing to Clinical Trials in North America
• Clinical Trials by G7 Countries: Proportion of Marfan Syndrome to Genetic Disorders Clinical Trials
• Clinical Trials by Phase in G7 Countries
• Clinical Trials in G7 Countries by Trial Status
• Clinical Trials by Phase
• Clinical Trials by Trial Status
• Clinical Trials by End Point Status
• Clinical Trials by Sponsor Type
• Prominent Sponsors
• Top Companies Participating in Marfan Syndrome Therapeutics Clinical Trials
• Prominent Drugs
• Clinical Trial Profile Snapshots

Appendix

• Abbreviations
• Definitions
• Research Methodology
• Secondary Research
• About GlobalData
• Contact Us
• Source